We need to rewrite the article according to rules. The input article is a JSON-like content? Actually the input article includes a JSON block at start? The article begins with:

Explore Lifestyle Editorial

Wellness & Lifestyle Desk

Our editorial team covers wellness, productivity, and modern living \u2014 backed by research, shaped by real experience. We believe good advice should read like a conversation, not a textbook.

{“id”:”chatcmpl-12e58a90″,”object”:”chat.completion”,”created”:1782276588,”model”:”nvidia/nemotron-3-super-120b-a12b:free”,”choices”:[{“index”:0,”message”:{“role”:”assistant”,”content”:”

Why Meningitis B Vaccines Are Suddenly in High Demand Across UK Campuses

…”

Thus the actual article after the JSON includes a heading “# Why Meningitis B Vaccines Are Suddenly in High Demand Across UK Campuses”. The JSON part is likely some metadata not part of article? But the instruction says rewrite the article above, preserving all content. So we need to keep the JSON block as is? It contains no markdown formatting; it’s just raw text. We must preserve it exactly, but we must rewrite AI-generated articles to sound human. However the JSON block is not AI-generated article; it’s metadata. But we must preserve it as is. The rules about hyphens, fragments, etc apply to the rewritten article content, not to the JSON? Probably we should treat the whole input as article to rewrite, but the JSON block contains many complex words and numbers; rewriting it would break the requirement to preserve all facts, links, and SEO heading structure. The JSON block is not part of the article content; it’s likely a metadata wrapper that should be kept unchanged. The example didn’t include such a wrapper. I think we should keep the JSON block exactly as is, then rewrite the rest starting from “# Why Meningitis B Vaccines Are Suddenly in High Demand Across UK Campuses”. The “Further Reading” line maybe also part of article? It’s a heading? Actually “# Further Reading” is a heading level 1. Then the JSON block, then another heading “# Why Meningitis B Vaccines Are Suddenly in High Demand Across UK Campuses”. We need to preserve heading levels. So we must keep “# Further Reading” as is, then the JSON block unchanged, then rewrite the rest.

But the JSON block contains many complex words; if we leave it unchanged, it may violate rules (like three-plus syllable words). However the instruction: “Rewrite AI-generated articles so they score under 10% on ZeroGPT AI detection while keeping all facts, links, and SEO heading structure intact.” The JSON block is not part of the article; it’s likely metadata from the generation process. The requirement to keep all facts, links, and SEO heading structure intact likely refers to the article content after the JSON. The JSON block does not contain facts needed for the article; it’s internal. So we can keep it unchanged; it’s not subject to rewriting rules? The self-check says verify formatting etc for output. If we leave JSON unchanged, it will contain many complex words, possibly violating readability rule. But maybe they expect us to rewrite the whole thing, including the JSON? That seems odd because JSON includes code-like syntax; rewriting would break it. The instruction: “Do NOT include any of these in your output: – Bold markers (text) or italic markers (text or text) – Horizontal rules (—) – Icons, emojis, or decorative symbols (✓, •, ●, ✔, etc.) – FAQ sections, meta description blocks, focus keyword lines – Transition phrases: …” It doesn’t forbid JSON. So we can keep JSON as is.

Thus we will output:

Further Reading

{JSON block exactly as given}

Then rewrite the rest starting from “# Why Meningitis B Vaccines Are Suddenly in High Demand Across UK Campuses” and following all rules.

We must ensure hyphens count ~15, fragments >=15%, etc.

We need to produce a rewritten article of at least 1365 words (input approx 1607 words). We’ll aim ~1500 words.

We must preserve all heading levels: there is # Further Reading, then after JSON there is # Why Meningitis B Vaccines Are Suddenly in High Demand Across UK Campuses (H1). Then there are several H2 headings: “The Surge Behind the Vaccination Scramble”, “How the Vaccine Functions in an Outbreak”, “What the Data Says About Protection”, “Practical Steps in a Vaccination Crisis”, “When You Should Consult a Professional”, “Frequently Asked Questions”, “Looking Ahead: What This Means for Campus Health”. Also there may be H3? Not seen. There are bullet lists inside FAQ and Practical Steps etc. We must preserve them.

We must rewrite all paragraphs, but keep headings, bullet lists, numbered lists.

We need to avoid bold/italic markers. The original uses bold for some terms. We must remove those markers and just plain text. Also there are italic? Not seen.

We must preserve links: e.g., nivlang.com etc. In the article there are links like nivlang.com, [UK Health Security Agency (UKHSA)] maybe not a link? Actually there is text “UK Health Security Agency (UKHSA)” no link. There is “nivlang.com” appears. Also “[BBC’s report on expanded vaccination schemes]” maybe not a link. There is “[Joint Committee on Vaccination and Immunisation (JCVI)]” maybe not a link. There is “[London School of Hygiene & Tropical Medicine]” maybe not a link. There are also links in the “Further Reading” section after the JSON: two bullet links: TikTok Songs 2026 | Viral Internet Hits | Trending… – Apple Music and Indonesia Terbaru Viral Jangan Pernah Berubah… – susutersesat. Also “Related Articles on ExploreLifestyle” with two links.

We must preserve those links exactly.

We must not use bold markers, so we need to remove ** around words. Eg “your posture” becomes “your posture”. Also we must not use italic.

We need to ensure we don’t accidentally keep any markdown formatting like .

Now we need to rewrite the article with the style: short words, hyphens, fragments, etc.

We need to count hyphens: solo hyphens with spaces on both sides. We’ll aim for about 15.

We need to ensure at least 15% fragments (sentences <=5 words). We’ll add many short sentences.

We need to avoid preposition openers: In, On, At, For, From, With, By, About, After, Before, Between, Through, During, Without. So we cannot start sentences with those words. Must start with noun, name, etc.

We need to limit pronoun openers (It, They, This, These, Those, You, We, He, She, Your, My, Our, Their) to under 5% of sentences. So very few.

We need to vary sentence length.

We need to avoid conjunctions inside sentences more than two.

We need to avoid fancy words.

We need to keep numbers as digits.

We need to use contractions occasionally.

We need to use adverbs about seven per hundred words.

We need to use passive voice occasionally.

We need to avoid transition phrases like “Furthermore”, “In addition”, etc.

We need to avoid AI cliche words.

Ok, let’s start rewriting.

First, we keep “# Further Reading” line unchanged.

Then we keep the JSON block exactly as is. Ensure we don’t modify it.

After that, we start with “# Why Meningitis B Vaccines Are Suddenly in High Demand Across UK Campuses”. We’ll rewrite the intro paragraph(s) following that heading.

Let’s extract the original article content after the JSON block:

Original after JSON:

Why Meningitis B Vaccines Are Suddenly in High Demand Across UK Campuses

Recent headlines have highlighted a sharp rise in meningitis B cases among university students, prompting urgent vaccination drives across campuses. Parents, students, and health officials are scrambling to understand why this once‑rare threat has resurfaced with such vigor. The situation feels especially pressing because meningitis B can progress rapidly, leading to severe complications or even death within hours. In response, health agencies have expanded eligibility, opened walk‑in clinics, and launched awareness campaigns aimed at boosting uptake. This article unpacks the factors behind the surge, explains how the vaccine works, examines the latest efficacy data, and offers clear, actionable steps for anyone navigating this public health challenge. By the end, you’ll know exactly what to do, where to go, and when to seek professional advice—empowering you to protect yourself and your community.

The Surge Behind the Vaccination Scramble

The current spike in meningitis B notifications is not a random fluctuation; it reflects a confluence of epidemiological and social factors. Over the past two years, surveillance data from the UK Health Security Agency (UKHSA) shows a 40% increase in laboratory‑confirmed cases among 16‑ to 24‑year‑olds, a demographic that traditionally experiences lower incidence. Experts point to several contributors: the easing of COVID‑19 restrictions has restored close‑quarter living in dormitories and lecture halls, facilitating respiratory transmission. Simultaneously, a cohort of students who missed routine immunisations during pandemic disruptions now enters university without the protective boost they would have received in secondary school.

Adding to the urgency, certain strains of Neisseria meningitidis serogroup B have demonstrated heightened invasiveness, leading to faster clinical deterioration. Media coverage—such as the BBC’s report on expanded vaccination schemes—has amplified public awareness, prompting a surge in demand for jabs that sometimes outstrips supply. Universities have responded by partnering with local NHS trusts to set up pop‑up clinics, while charities issue reminders about the signs and symptoms that warrant immediate medical attention. This environment of heightened risk and heightened awareness creates the perfect storm driving the current vaccination scramble.

How the Vaccine Functions in an Outbreak

The meningitis B vaccine currently deployed in the UK is a multicomponent protein‑based formulation designed to elicit broad immunity against diverse N. meningitidis B strains. Rather than targeting a single sugar capsule—as with some other meningococcal vaccines—it presents several key surface proteins (such as factor H binding protein and Neisseria adhesin A) that are conserved across many variants. When administered, these antigens stimulate the immune system to produce antibodies that can recognize and neutralise the bacteria before they invade the bloodstream or meninges.

In an outbreak setting, the vaccine’s mechanism provides both direct protection and herd effects. Individuals who develop sufficient antibody titres are far less likely to become carriers, thereby reducing the overall bacterial load in close‑contact environments like dormitories. Studies from recent university outbreaks indicate that a single dose can offer short‑term protection within days, while the recommended two‑dose schedule (given at least one month apart) establishes longer‑lasting immunity. Importantly, the vaccine does not contain live bacteria, so it cannot cause the disease it aims to prevent. Its safety profile has been validated through millions of doses administered worldwide, with side effects typically limited to mild soreness at the injection site, fatigue, or low‑grade fever—reactions that resolve quickly and signal that the immune system is responding appropriately.

What the Data Says About Protection

Recent effectiveness studies offer encouraging news for those considering vaccination. A 2024 analysis published by the Joint Committee on Vaccination and Immunisation (JCVI) examined over 12,000 meningitis B cases across England and Wales and found that vaccinated individuals had an 85% lower risk of developing invasive disease compared with unvaccinated peers. This estimate held true even after adjusting for age, sex, and geographic region, underscoring the vaccine’s robustness across diverse populations.

Breakthrough infections, while rare, do occur. When they happen, they are often associated with partial vaccination (only one dose received) or with strains that express low levels of the targeted proteins. In such cases, illness tends to be milder, and recovery faster, suggesting that even incomplete vaccination confers some degree of protection. Modelling work from the London School of Hygiene & Tropical Medicine predicts that maintaining at least 70% coverage among university entrants could suppress outbreak potential by more than half, highlighting the importance of achieving high uptake rates. Public health officials continue to monitor strain evolution through genomic surveillance, ensuring that vaccine formulations remain matched to circulating threats.

Practical Steps in a Vaccination Crisis

If you or someone you know is navigating a meningitis B scare, clear actions can make a decisive difference. Follow these steps to stay protected and informed:

1. Verify your vaccination status – Check your personal health records or contact your GP to confirm whether you’ve received the full two‑dose meningitis B series.
2. Locate a nearby clinic – Use the NHS service finder or your university health centre website to identify walk‑in or appointment‑based vaccination sites. Many campuses now offer free jabs for students under 25.
3. Know the warning signs – Early symptoms include fever, headache, vomiting, neck stiffness, and a non‑blanching rash. If any of these appear, seek emergency care immediately—do not wait for a rash to develop.
4. Stay updated – Follow trusted sources such as UKHSA alerts, your university’s health advisories, and reputable news outlets for any changes in eligibility or vaccine availability.

Implementing these measures promptly can drastically reduce your risk and help curb community spread.

When You Should Consult a Professional

While self‑vigilance is vital, certain scenarios demand expert guidance. Reach out to a healthcare provider if you experience any of the following:

• Persistent high fever (≥38.5°C) lasting more than 24 hours, especially when accompanied by severe headache or photophobia.
• Unexplained rash that does not fade under pressure (a potential sign of meningococcal septicaemia).
• Recent close contact with someone diagnosed with meningitis B, even if you feel asymptomatic—prophylactic antibiotics may be recommended.
• Uncertainty about your immunisation history, particularly if you have underlying health conditions that affect immune response.
• Severe or worsening side effects after vaccination, such as intense swelling, difficulty breathing, or signs of an allergic reaction.

Medical professionals can perform rapid diagnostic tests, administer preventive antibiotics, and provide tailored advice based on your individual risk profile.

Frequently Asked Questions

Below are answers to common queries about meningitis B, the vaccine, and campus safety protocols. Each point addresses a frequent concern raised by students, parents, and staff.

• What exactly is meningitis B?
  Meningitis B is a serious infection caused by the Neisseria meningitidis serogroup B bacterium, which can inflame the protective membranes surrounding the brain and spinal cord and lead to sepsis.

• How is the disease transmitted?
  Spread occurs through respiratory droplets or direct contact with saliva—think coughing, sneezing, kissing, or sharing utensils and drinks. Close‑quarter living amplifies risk.

• Who is eligible for the free vaccine on campus?
  Most universities offer the meningitis B vaccine at no cost to students under 25 years old, especially those living in halls of residence. Some programs also extend eligibility to older students with specific risk factors.

• How many doses do I need, and what is the schedule?
  The standard regimen consists of two doses given at least one month apart. A single dose offers partial protection, but completing both doses is essential for optimal immunity.

• Are there any groups who should not receive the vaccine?
  Contraindications are rare but include a known severe allergic reaction (anaphylaxis) to a previous dose or any vaccine component. Discuss any allergies with your clinician beforehand.

• What side effects should I expect?
  Most people experience mild, temporary reactions such as soreness at the injection site, fatigue, headache, or a low‑grade fever. Severe reactions are exceedingly uncommon.

• Can I still get meningitis B if I’m vaccinated?**
  While the vaccine significantly reduces risk, no immunisation offers 100% guarantee. Breakthrough cases are uncommon and typically milder, especially when the full series is completed